TrialBlood2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Guillaume P Andrieu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
TrialBlood2021
Guillaume P Andrieu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.